Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,786 | 55,333 | 45,204 | 56,514 | 66,830 |
| Marketable Securities | N/A | N/A | 35,798 | 75,597 | 76,271 |
| Receivables | 581 | 691 | 923 | 1,750 | 3,935 |
| Other current assets | 0 | 0 | 3,144 | 0 | 0 |
| TOTAL | $40,075 | $68,636 | $94,328 | $147,576 | $159,609 |
| Non-Current Assets | |||||
| PPE Net | 20,619 | 22,017 | 26,874 | 28,436 | 60,717 |
| Investments And Advances | 0 | 0 | 0 | 0 | 39,037 |
| Other Non-Current Assets | 32,320 | 38,308 | 44,118 | 43,685 | 65,711 |
| TOTAL | $52,939 | $60,325 | $70,992 | $72,121 | $165,465 |
| Total Assets | $93,014 | $128,961 | $165,320 | $219,697 | $325,074 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,590 | 15,468 | 15,259 | 15,457 | 14,837 |
| Accrued Expenses | 5,655 | 6,300 | 8,918 | 17,306 | 13,118 |
| TOTAL | $39,005 | $40,242 | $47,731 | $48,482 | $53,792 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 1,485 | 6,873 |
| Other Non-Current Liabilities | 30,319 | 32,022 | 34,702 | 36,293 | 37,640 |
| TOTAL | $30,319 | $32,022 | $34,702 | $36,293 | $37,640 |
| Total Liabilities | $69,324 | $72,264 | $82,433 | $84,775 | $91,432 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 208,221 | 207,510 | 178,906 | 177,347 | 177,112 |
| Common Shares | 2,082 | 2,037 | 1,781 | 1,773 | 1,771 |
| Retained earnings | -1,491,593 | -1,455,465 | -1,406,376 | -1,346,081 | -1,241,918 |
| Other shareholders' equity | -5,883 | -5,801 | -4,595 | -6,581 | -5,936 |
| TOTAL | $23,690 | $56,697 | $82,887 | $134,922 | $233,642 |
| Total Liabilities And Equity | $93,014 | $128,961 | $165,320 | $219,697 | $325,074 |